@kaustuva_das
CEO @ThermalPR + PR for Jennifer Doudna, Nobel Laureate and CRISPR pioneer
Science
One post says Casgevy's FDA approval expanded to children as young as two with sickle cell disease or beta-thalassemia.
Science
